Determining the effect of Toll-like Receptor-7 on Systemic Lupus Erythematosus Development
Vol: 2013, Issue: 1
2013
- 10Usage
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Usage10
- Downloads8
- Abstract Views2
Artifact Description
Systemic Lupus Erythematosus (Lupus) is an autoimmune disease that afflicts over 250,000 citizens of the United States. Although much remains to be learned about Lupus, the information gathered so far has proven to be extremely valuable in increasing survival rates and improving the quality of life of Lupus patients. As we continue to put time and energy into Lupus research, the result will be that we will be able to combat the disease more effectively. The first step in combating Lupus is to gain knowledge about the pathogenesis and mechanisms of the disease. By further developing our knowledge, we will be able to develop new ways to prevent and treat, or lessen the symptoms of, Lupus.
Bibliographic Details
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know